Cancer prevention in ulcerative colitis: Long-term outcome following fluorescence-guided colonoscopy

Inflammatory Bowel Diseases

Volumn 18, Issue 3, 2012, Pages 489-495

  Fusco, Virginia ^a   Ebert, Bernd ^a   Weber Eibel, Jutta ^b   Jost, Christian ^c   Fleige, Barbara ^e   Stolte, Manfred ^d   Oberhuber, Georg ^f   Rinneberg, Herbert ^a   Lochs, Herbert ^g   Ortner, Marianne ^c  

^a Mediankliniken Gruenheide ^*  (Germany)

^b GENERAL HOSPITAL KLAGENFURT   (Austria)

^c UNIVERSITY OF BERN   (Switzerland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e Clinical Centre Kulmbach   (Germany)

^f Clinical Centre Ueberlingen   (Germany)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

colorectal cancer; fluorescence guided colonoscopy; low grade dysplasia; surveillance; ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; MERCAPTOPURINE; PREDNISOLONE;

ADULT; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLON CANCER; COLON RESECTION; COLONOSCOPY; FEMALE; FLUORESCENCE GUIDED COLONOSCOPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ULCERATIVE COLITIS;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; COLECTOMY; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; FLUORESCENCE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 84857368189     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21703     Document Type: Article

References (25)

1. Jess T, Loftus EV, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005; 100: 2724-2729.
2. Velayos FS, Lui L, Lewis JD, et al. Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health-care delivery system. Gastroenterology. 2010; 139: 1511-1508.
3. Pekow JR, Hetzel IT, Roche JA, et al. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis. 2010; 16: 1352-1356.
4. Ullmann TA, Croog V, Harpaz N, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003; 125: 1311-1319. (Pubitemid 37409751)
5. Ortner MA, Fusco V, Ebert B, et al. Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis. Gastrointest Endosc. 2010; 71: 312-318.
6. Lim CH, Dixon MF, Vail A, et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut. 2003; 52: 1127-1132. (Pubitemid 36877424)
7. Woolrich AJ, DaSilva MD, Korelitz Bi, et al. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology. 1993; 10: 666-667.
8. Rutter MD, Saunders BP, Wilkinson KH, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. 2006; 130: 1030-1038.
9. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 1994; 107: 934-944. (Pubitemid 24294554)
10. Itzkowitz SH, Present DH,. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 314-321. (Pubitemid 40439686)
11. Eaden JA, Mayberry JF,. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut. 2002; 51 (suppl V): 10-12.
12. Vanden Broek FJC, Fockens P, van Eeden S, et al. Endoscopic tri-modal imaging for surveillance in ulcerative colitis: a randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut. 2008; 57: 1083-1089.
13. Hurlstone DP, Kiesslich R, Thomson R, et al. Chromoendoscopy alone for the detection and characterization of intraepithelial neoplasia in chronic ulcerative colitis. Gut. 2008; 57: 196-209.
14. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003; 124: 880-88. (Pubitemid 36389789)
15. Machida H, Sano Y, Hamahmoto Y, et al. Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study. Endosocpy. 2004; 36: 1094-1098. (Pubitemid 39642471)
16. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal neoplasia. Gut. 2000; 47: 251-255.
17. Truelove SC, Richards WCD,. Biopsy studies in ulcerative colitis. BMJ. 1956; 1: 1315-1318.
18. Kruis W, Schreiber S, Theuer, et al. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 h three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses. Gut. 2001; 49: 783-789. (Pubitemid 33096035)
19. Rachmilewitz D,. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis. A randomized study. BMJ. 1989; 298: 82-86. (Pubitemid 19032930)
20. Schroeder KW, Tremaine WJ,. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active colitis. A randomized study. N Engl J Med. 1987; 317: 1625-1629. (Pubitemid 18010466)
21. Befrits R, Ljung T, Jaramillo E, Rubio C, et al. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum. 2002; 45: 615-620. (Pubitemid 34507236)
22. Gorfine SR, Bauer JJ, Harris MT, et al. Dysplasia complicating chronic ulcerative colitis is immediate colectomy warranted? Dis Colon Rectum. 2000; 43: 1578-1581.
23. Messmann H, Endlicher E, Freunek G, et al. Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitization. Gut. 2003; 52: 1003-1007. (Pubitemid 36765293)
24. Ochsenkühn T, Tillack C, Stepp H, et al. Low frequency of colorectal dysplasia in patients with long-standing inflammatory bowel disease colitis: detection by fluorescence endoscopy. Endoscopy. 2006; 38: 477-482. (Pubitemid 43744705)
25. Gondal G, Grotmol T, Hofstad B, et al. Biopsy of colorectal polyps is not adequate for grading of neoplasia. Endoscopy. 2005; 37: 1193-1197. (Pubitemid 41763535)